Author:
da Costa Capizzani C. P.,Caçador N. C.,Torres L. A. G. M. M.,Tonani L.,Vandamme P.,da Costa Darini A. L.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference40 articles.
1. Hauser AR, Jain M, Bar-Meir M, McColley SA (2011) Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 24:29–70. doi: 10.1128/CMR.00036-10
2. Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ et al (2013) Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One 8:e62917. doi: 10.1371/journal.pone.0062917
3. Chmiel JF, Konstan MW, Elborn JS (2013) Antibiotic and anti-inflammatory therapies for cystic fibrosis. Cold Spring Harb Perspect Med 3:a009779. doi: 10.1101/cshperspect.a009779
4. De Smet B, Mayo M, Peeters C, Zlosnik JE, Spilker T, Hird TJ et al (2015) Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. Int J Syst Evol Microbiol 65:2265–2271. doi: 10.1099/ijs.0.000251
5. Lupo A, Isis E, Tinguely R, Endimiani A (2015) Clonality and antimicrobial susceptibility of Burkholderia cepacia complex isolates collected from cystic fibrosis patients during 1998–2013 in Bern, Switzerland. New Microbiol 38:281–288
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献